NDC 76310-024-15 - Foscavir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76310-024
- Requested NDC
- 76310-024-15
- Package NDCs from labels
- 76310-024-15, 76310-024-25, 76310-024-11, 76310-024-01, 76310-024-41, 76310-024-45
- Manufacturer
- Clinigen Limited
- Effective date
- 2025-12-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Foscavir - Clinigen Limited | Clinigen Limited | 2025-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Foscavir - Clinigen Limited | Clinigen Limited | 2025-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Foscavir - Clinigen Limited | Clinigen Limited | 2023-11-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76310-024-15 | Foscavir | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 22 | |
| 76310-024-15 | Foscavir | 250 mL in 1 BOTTLE | INJECTION, SOLUTION | 250 | 22 | |
| 76310-024-25 | Foscavir | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 22 | |
| 76310-024-01 | Foscavir | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 16 | |
| 76310-024-11 | Foscavir | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 16 | |
| 76310-024-11 | Foscavir | 250 mL in 1 BOTTLE | INJECTION, SOLUTION | 250 | 16 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76310-024 | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN LIMITED] | 21 | Current NDC, Legacy NDC, 3 package rows | 20241122_a09299d5-9c55-4cef-aed0-3a6a45532289.zip |
| 76310-024 | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN LIMITED] | 15 | Current NDC, Legacy NDC, 3 package rows | 20241122_90e3da4e-3b1f-428b-99ca-e4bed1c80028.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76310-024-01 | ML - Milliliter | 76310-024 | d42ef6be-3360-41b4-979d-2ed71db24493 | 1 | 2015-03-03 |
| 76310-024-11 | ML - Milliliter | 76310-024 | e864fc20-812d-4db6-bf3d-ae61ddc14434 | 1 | 2019-05-02 |
| 76310-024-15 | ML - Milliliter | 76310-024 | c6522f73-3765-465b-8ae0-02b16a63fe2c | 1 | 2018-08-13 |
| 76310-024-25 | ML - Milliliter | 76310-024 | 97ab2e67-b14b-45cf-9c0f-a1eb895f75aa | 1 | 2013-02-13 |
| 76310-024-41 | ML - Milliliter | 76310-024 | 76dcf366-1dee-4a3b-8b56-8b106690bb42 | 1 | 2021-05-05 |
| 76310-024-45 | ML - Milliliter | 76310-024 | f43f7d6d-fa25-4dec-ab95-c3467b5d4590 | 1 | 2021-04-08 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| foscarnet sodium | ACTIVE INGREDIENT | 964YS0OOG1 | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 8 | |
| foscarnet | ACTIVE MOIETY | 364P9RVW4X | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 8 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 8 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 8 | |
| foscarnet sodium | ACTIVE INGREDIENT | 964YS0OOG1 | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 2 | |
| foscarnet | ACTIVE MOIETY | 364P9RVW4X | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 2 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | FOSCAVIR (FOSCARNET SODIUM) INJECTION, SOLUTION [CLINIGEN HEALTHCARE LTD.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643994f-4e13-4572-e053-2991aa0a5b78 | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 6907bbfe-caa5-2ce4-e053-2991aa0ade8d | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643c518-13b2-658a-e053-2a91aa0ac5ed | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643e30e-1f47-09f1-e053-2991aa0ac2de | 2023-11-14 | QTT17582CB | |
| CV TOX | COCHLEARIA ARMORACIA, ECHINACEA (ANGUSTIFOLIA), LOMATIUM DISSECTUM, TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, PROPOLIS, GLANDULA SUPRARENALIS BOVINE, THYMUS (SUIS), ARANEA DIADEMA, IPECACUANHA, LYCOPODIUM CLAVATUM, MURIATICUM ACIDUM, NITRICUM ACIDUM, PHOSPHORICUM ACIDUM, RHUS TOX, SILICEA, EPSTEIN-BARR VIRUS NOSODE, HERPES ZOSTER NOSODE, MORBILLINUM, POLIOMYELITIS NOSODE, HEPATITIS B NOSODE, COXSACKIE B1 NOSODE, CYTOMEGALOVIRUS NOSODE, COXSACKIE B4 NOSODE, EPSTEIN BARR VIRUS NOSODE | BioActive Nutritional, Inc. | 8ef2fb5c-1b24-46a1-8d21-a78ce0a34a87 | 2023-11-07 | Warnings | QTT17582CB |
| Ahh Sleep | COFFEA CRUDA | Micro Balance Health Products | 08ea860f-0183-8ce8-e063-6394a90a582b | 2023-10-30 | Warnings | QTT17582CB |
| Stomach Enzyme Formula | BETAINUM MURIATICUM, MURIATICUM ACIDUM, NATRUM PHOSPHORICUM, PANCREAS SUIS, STOMACH (SUIS) SYMPHYTUM OFFICINALE, PEPSINUM | Nutritional Specialties, Inc. | 992e6f61-abc9-4146-a9da-5ada4a627aa7 | 2023-10-04 | Warnings | QTT17582CB |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SODIUM BICARBONATE, ALOE BARBADENSIS LEAF JUICE, IMIDAZOLIDINYL UREA | ANUBIS COSMETICS SL | ebf4b3ab-34e1-185a-e053-2a95a90ace3a | 2023-09-05 | Warnings | 059QF0KO0R |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE | ANUBIS COSMETICS SL | f22b212d-d21d-5984-e053-2995a90a683e | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Vital Line | HYDROLYZED ELASTIN, HYDROLYSED COLLAGEN, COCOGLYCERIDES | ANUBIS COSMETICS SL | ebe024f7-7c45-ad60-e053-2995a90a45d6 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.